A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial carcinoma: A gynecologic oncology group study
David L. Tait; John A. Blessing; James S. Hoffman; Kathleen N. Moore; Nick M. Spirtos; Jason A. Lachance; Jacob Rotmensch; David S. Miller
- 作者David L. Tait; John A. Blessing; James S. Hoffman; Kathleen N. Moore; Nick M. Spirtos; Jason A. Lachance; Jacob Rotmensch; David S. Miller
- 卷第121卷
- 期第1期
- 印刷ISSN0090-8258
- 电子ISSN1095-6859
- 文件大小151.29KB
- 发表时间2011
- DOI10.1016/j.ygyno.2010.11.027
- 页码118-121